The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bassler Bonnie L since 2020.
This trader's CIK number is 1683607.
At the time of last reporting, Bassler Bonnie L was the Director of Regeneron Pharmaceuticals, Inc.. (stock ticker symbol REGN).
Also see all insider trading activities at Regeneron Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | REGN | 0 | $0 | 5,602 | $5,750,765 | 5,602 | $2,121,787 |
2023 | REGN | 0 | $0 | 4,577 | $3,720,533 | 4,577 | $1,759,721 |
2022 | REGN | 0 | $0 | 2,480 | $1,767,000 | 2,480 | $944,756 |
2021 | REGN | 0 | $0 | 3,778 | $2,303,370 | 3,778 | $1,462,108 |
2020 | REGN | 0 | $0 | 5,118 | $3,149,335 | 5,118 | $2,005,846 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-08-15 | REGN | Option Ex | 756 | 371.40 | 280,778 |
2024-08-15 | REGN | Sale | 756 | 1,170.00 | 884,520 |
2024-08-02 | REGN | Option Ex | 756 | 371.40 | 280,778 |
2024-08-02 | REGN | Sale | 756 | 1,115.00 | 842,940 |
2024-06-24 | REGN | Sale | 756 | 1,062.00 | 802,872 |
2024-06-24 | REGN | Option Ex | 756 | 371.40 | 280,778 |
2024-06-05 | REGN | Option Ex | 827 | 380.95 | 315,045 |
2024-06-05 | REGN | Sale | 827 | 1,011.00 | 836,097 |
2024-02-26 | REGN | Sale | 854 | 979.25 | 836,279 |
2024-02-26 | REGN | Option Ex | 854 | 391.92 | 334,699 |
2024-01-30 | REGN | Option Ex | 827 | 380.95 | 315,045 |
2024-01-30 | REGN | Sale | 827 | 959.00 | 793,093 |
2024-01-03 | REGN | Sale | 826 | 914.00 | 754,964 |
2024-01-03 | REGN | Option Ex | 826 | 380.95 | 314,664 |
2023-12-13 | REGN | Option Ex | 610 | 376.69 | 229,780 |
2023-12-13 | REGN | Sale | 610 | 870.00 | 530,700 |
2023-08-21 | REGN | Option Ex | 853 | 391.92 | 334,307 |
2023-08-21 | REGN | Sale | 853 | 829.00 | 707,137 |
2023-08-10 | REGN | Option Ex | 853 | 391.92 | 334,307 |
2023-08-10 | REGN | Sale | 853 | 789.00 | 673,017 |
2023-03-24 | REGN | Option Ex | 1,240 | 380.95 | 472,378 |
2023-03-24 | REGN | Sale | 1,240 | 818.00 | 1,014,320 |
2023-02-03 | REGN | Option Ex | 1,021 | 380.95 | 388,949 |
2023-02-03 | REGN | Sale | 1,021 | 779.00 | 795,359 |
2022-04-07 | REGN | Option Ex | 1,240 | 380.95 | 472,378 |
2022-04-07 | REGN | Sale | 1,240 | 725.00 | 899,000 |
2022-03-30 | REGN | Sale | 1,240 | 700.00 | 868,000 |
2022-03-30 | REGN | Option Ex | 1,240 | 380.95 | 472,378 |
2021-08-16 | REGN | Option Ex | 1,219 | 376.69 | 459,185 |
2021-08-16 | REGN | Sale | 1,219 | 630.00 | 767,970 |
2021-08-05 | REGN | Option Ex | 2,559 | 391.92 | 1,002,923 |
2021-08-05 | REGN | Sale | 2,559 | 600.00 | 1,535,400 |
2020-06-19 | REGN | Option Ex | 2,559 | 391.92 | 1,002,923 |
2020-06-19 | REGN | Sale | 2,559 | 630.69 | 1,613,935 |
2020-06-05 | REGN | Option Ex | 2,559 | 391.92 | 1,002,923 |
2020-06-05 | REGN | Sale | 2,559 | 600.00 | 1,535,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bassler Bonnie L (Director of Regeneron Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.